glp-1analogs
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| glp-1analogs [2026/07/24 05:43] – [Adverse effects and C/I] gary1 | glp-1analogs [2026/07/24 05:44] (current) – [Adverse effects and C/I] gary1 | ||
|---|---|---|---|
| Line 43: | Line 43: | ||
| *risk of [[hypoglycaemia]] is increased if the drug is used in combination with sulfonylureas or insulin | *risk of [[hypoglycaemia]] is increased if the drug is used in combination with sulfonylureas or insulin | ||
| *increases risk of **diabetic retinopathy** by 50-80% (([[https:// | *increases risk of **diabetic retinopathy** by 50-80% (([[https:// | ||
| - | *increased risk of **permanent blindness | + | *increased risk of **permanent blindness |
| * typically presents as blindness suddenly upon waking and without pain | * typically presents as blindness suddenly upon waking and without pain | ||
| * risk is also increased if they have diabetes, sleep apnea, hypertension or having a crowded optic disc | * risk is also increased if they have diabetes, sleep apnea, hypertension or having a crowded optic disc | ||
glp-1analogs.txt · Last modified: 2026/07/24 05:44 by gary1